Fate Therapeutics
FATE
#8433
Rank
C$0.33 B
Marketcap
C$2.88
Share price
4.57%
Change (1 day)
67.04%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026C$0.34 M-74.93%
2025C$1.38 M14.86%
2024C$1.2 M-44.15%
2023C$2.15 M-89.19%
2022C$19.92 M-20.28%
2021C$24.99 M31.2%
2020C$19.05 M9.95%
2019C$17.32 M59.52%
2018C$10.86 M1415.4%
2017C$0.71 M181.93%
2016C$0.25 M-79.05%
2015C$1.21 M-17.49%
2014C$1.47 M-81.78%
2013C$8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Becton Dickinson
BDX
C$59.38 MC$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$9.11 MC$23.47 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$4.79 MC$22.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$13.95 MC$26.48 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$0.17 MC$40.27 M๐Ÿ‡บ๐Ÿ‡ธ USA